ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

ASSIST Smoking Intervention gets Under Way In 1991

December 1, 1989

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

U.S. Breast Cancer Death Rate Declines.

September 28, 2007

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998